The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription

Katharine Umphred-Wilson, Shashikala Ratnayake, Qianzi Tang, Rui Wang, Sneha Ghosh Chaudhary, Devaiah N. Ballachanda, Josephine Trichka, Jan Wisniewski, Lan Zhou, Qingrong Chen, Daoud Meerzaman, Dinah S. Singer, Stanley Adoro

Research output: Contribution to journalArticlepeer-review

Abstract

Addiction to oncogene-rewired transcriptional networks is a therapeutic vulnerability in cancer cells, underscoring a need to better understand mechanisms that relay oncogene signals to the transcriptional machinery. Here, using human and mouse T cell acute lymphoblastic leukemia (T-ALL) models, we identify an essential requirement for the endosomal sorting complex required for transport protein CHMP5 in T-ALL epigenetic and transcriptional programming. CHMP5 is highly expressed in T-ALL cells where it mediates recruitment of the coactivator BRD4 and the histone acetyl transferase p300 to enhancers and super-enhancers that enable transcription of T-ALL genes. Consequently, CHMP5 depletion causes severe downregulation of critical T-ALL genes, mitigates chemoresistance and impairs T-ALL initiation by oncogenic NOTCH1 in vivo. Altogether, our findings uncover a non-oncogene dependency on CHMP5 that enables T-ALL initiation and maintenance.

Original languageEnglish (US)
Article number4133
JournalNature Communications
Volume16
Issue number1
DOIs
StatePublished - Dec 2025

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'The ESCRT protein CHMP5 promotes T cell leukemia by enabling BRD4-p300-dependent transcription'. Together they form a unique fingerprint.

Cite this